Through the generosity of the Johns Hopkins Center for Innovative Medicine (CIM) donors, the Johns Hopkins Department of Medicine received $3 million to launch the Center for Innovative Medicine Next Generation Scholar Awards. The program is designed to support the success of outstanding early-career faculty members who are innovators in the areas of research, education and clinical care. Scholars are unanimously selected by the CIM Next Generation Scholar Review Committee.

Among this year's honorees are Matthew Robinson, M.D., assistant professor in the Division of Infectious Diseases, who is interested in using diagnostic innovation and precision medicine to reduce diagnostic and prognostic uncertainty for infectious diseases. With this award, he will leverage large language models for antibiotic stewardship and guideline-directed therapy at scale. Ethel Weld, M.D., Ph.D., associate professor in the Division of Clinical Pharmacology, aims to innovate and build knowledge around long-acting injectable antiretroviral therapy implementation in non-clinic-based settings, thus extending the reach of this potentially game-changing technology to engage those not already in care and those without viral suppression.

Both awardees are graduates of the Johns Hopkins ACGME Adult Infectious Diseases Fellowship Program; Robinson completed his training in 2017, and Weld completed hers in 2015.